August 5, 2009 โ Nile Therapeutics Inc. said this week it dosed its first patient in a phase 2 clinical study of ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
August 4, 2009 โ Watson Pharmaceuticals Inc. said this week it received FDA approval on its abbreviated new drug ...
August 3, 2009 โ Kowa Research Institute (KRI) and Kowa Pharmaceuticals America Inc. (KPA) said today the FDA has ...
July 31, 2009 โ United Therapeutics Corp. said yesterday the FDA approved TYVASO (treprostinil) Inhalation ...
July 28, 2009 โ Sanofi-aventis said today MULTAQ (dronedarone) 400 mg tablets are now available in pharmacies in ...
July 22, 2009 โ The FDA this week approved Tekturna HCT (aliskiren and hydrochlorothiazide) tablets as initial ...
July 13, 2009 โ Daiichi Sankyo Inc. and Eli Lilly and Company said Friday the FDA approved Effient (prasugrel) ...
July 10, 2009 โ Merck & Co. Inc. and Portola Pharmaceuticals Inc. this week signed an exclusive global ...
July 10, 2009 โ New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that ...
July 6, 2009 โ Sanofi-aventis said last week the FDA approved its Multaq (dronedarone) 400 mg tablets for use in ...
July 1, 2009 โ Cardioxyl Pharmaceuticals Inc. announced today the initiation of a phase I/IIa dose-escalation ...
June 29, 2009 โ Cordex Pharma said today it successfully completed the production of the ATPace clinical trial ...
June 15, 2009 - Mayo Clinic received $48 million in grants from the National Heart, Lung and Blood Institute ...
June 09, 2009 โ Talecris Biotherapeutics Inc., said today it was granted orphan drug designation by the FDA for ...
June 2, 2009 - Cordex Pharma Inc. said today the FDA cleared the design of pivotal, phase 2b/3 clinical trials ...